The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1S,4S)-2-(5-(benzo[b]thiophen-5-yl)pyridin-2-yl)-5-methyl-2,5-diazabicyclo[2.2.1]heptane ID: ALA1085090
PubChem CID: 46890953
Max Phase: Preclinical
Molecular Formula: C19H19N3S
Molecular Weight: 321.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3sccc3c2)cn1
Standard InChI: InChI=1S/C19H19N3S/c1-21-11-17-9-16(21)12-22(17)19-5-3-15(10-20-19)13-2-4-18-14(8-13)6-7-23-18/h2-8,10,16-17H,9,11-12H2,1H3/t16-,17-/m0/s1
Standard InChI Key: PBHJNCFSKUFXJI-IRXDYDNUSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
13.7212 1.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5357 1.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9417 1.7106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5357 2.4210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7212 2.4210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3083 1.7106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7536 1.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1606 1.0020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9740 0.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3862 1.7091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9757 2.4187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1602 2.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4937 1.7089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7149 1.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7149 3.2409 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.5294 0.1928 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
18.2116 1.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4480 2.4237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6230 2.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6255 0.9885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8653 1.7045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4523 0.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0063 0.3736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7618 0.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6744 1.5333 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
5 14 1 0
2 14 1 0
5 15 1 1
2 16 1 1
17 20 2 0
1 2 1 0
21 18 1 0
1 6 1 0
18 19 2 0
19 17 1 0
10 17 1 0
22 20 1 0
2 3 1 0
21 22 2 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.45Molecular Weight (Monoisotopic): 321.1300AlogP: 3.86#Rotatable Bonds: 2Polar Surface Area: 19.37Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.85CX LogP: 3.84CX LogD: 3.26Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.71Np Likeness Score: -1.10
References 1. Li T, Bunnelle WH, Ryther KB, Anderson DJ, Malysz J, Helfrich R, Grønlien JH, Håkerud M, Peters D, Schrimpf MR, Gopalakrishnan M, Ji J.. (2010) Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands., 20 (12): [PMID:20472430 ] [10.1016/j.bmcl.2010.04.105 ]